Galera Therapeutics Probability of Future Pink Sheet Price Finishing Over 0.0
Galera Therapeutics' future price is the expected price of Galera Therapeutics instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Galera Therapeutics performance during a given time horizon utilizing its historical volatility. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Please specify Galera Therapeutics' target price for which you would like Galera Therapeutics odds to be computed.
Galera |
Galera Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Galera Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Galera Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Galera Therapeutics is not yet fully synchronised with the market data | |
| Galera Therapeutics has some characteristics of a very speculative penny stock | |
| Galera Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (59.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Galera Therapeutics currently holds about 52.01 M in cash with (44.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.94. | |
| Roughly 36.0% of the company shares are held by company insiders |
Galera Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Galera Pink Sheet often depends not only on the future outlook of the current and potential Galera Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Galera Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44.5 M | |
| Cash And Short Term Investments | 18.3 M |
Galera Therapeutics Technical Analysis
Galera Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Galera Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Galera Therapeutics. In general, you should focus on analyzing Galera Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Galera Therapeutics Predictive Forecast Models
Galera Therapeutics' time-series forecasting models is one of many Galera Therapeutics' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Galera Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Galera Therapeutics
Checking the ongoing alerts about Galera Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Galera Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Galera Therapeutics is not yet fully synchronised with the market data | |
| Galera Therapeutics has some characteristics of a very speculative penny stock | |
| Galera Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (59.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Galera Therapeutics currently holds about 52.01 M in cash with (44.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.94. | |
| Roughly 36.0% of the company shares are held by company insiders |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Galera Pink Sheet
If you are still planning to invest in Galera Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Galera Therapeutics' history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |